Your browser doesn't support javascript.
loading
Phase 2 trial of induction with dasatinib and consolidation with hyper-CVAD plus dasatinib followed by allografting for Ph-positive acute lymphoblastic leukemia in adults.
Oh, Iekuni; Hatano, Kaoru; Ikeda, Takashi; Toda, Yumiko; Minakata, Daisuke; Kawaguchi, Shinichiro; Morita, Kaoru; Yamamoto, Chihiro; Ashizawa, Masahiro; Sato, Kazuya; Kameda, Kazuaki; Gomyo, Ayumi; Misaki, Yukiko; Kawamura, Shunto; Kimura, Shunichi; Kobayashi, Hiroyuki; Sato, Hiroyuki; Nakasone, Hideki; Ohmine, Ken; Fujiwara, Shinichiro; Kako, Shinichi; Kanda, Yoshinobu.
Afiliação
  • Oh I; Department of Hematology, Yuai Memorial Hospital, Koga 306-0232, Japan.
  • Hatano K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Ikeda T; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Toda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Minakata D; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Kawaguchi S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Morita K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Yamamoto C; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Ashizawa M; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Sato K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Kameda K; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Gomyo A; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Misaki Y; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Kawamura S; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Kimura S; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Kobayashi H; Department of Hematology, Nasu Red Cross Hospital, Tochigi 324-8686, Japan.
  • Sato H; Department of Hematology, Saitama Red Cross Hospital, Saitama 330-8553, Japan.
  • Nakasone H; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Ohmine K; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Fujiwara S; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
  • Kako S; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University, Tochigi 329-0498, Japan; Division of Hematology, Department of Medicine, Jichi Medical University Saitama Medical Center, Saitama 330-8503, Japan. Electronic address: ycanda-tky@umin.ac.jp.
Leuk Res ; 137: 107438, 2024 02.
Article em En | MEDLINE | ID: mdl-38278044
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Leuk Res Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adult / Humans Idioma: En Revista: Leuk Res Ano de publicação: 2024 Tipo de documento: Article